dry eye syndrom. Other disorders of lacrimal gland
Conditions
Interventions
Intervention 1: Intervention group: treatment with honey drops (prepared from Gavan honey, produced by "Kandu Asal" company
1% honey in Tearlose drops)
Three times a day, one drop each time for one month, (routine treatment of dry eyes will not be removed for this group of patients). Intervention 2: Control group: Standard treatment includes artifici
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients (male or female, without age limit) with dry eye syndrome (at three levels of low, moderate, and severe) Best corrected vision greater than or equal to 9/10 Schirmer test is less than 5 mm in 5 minutes Tear break time is less than 10 seconds
Exclusion criteria
Exclusion criteria: Patients with blepharitis disorder Patients with meibomian gland disorder Patients with a history of taking tetracycline for the past three months Patients with a history of taking oral corticosteroids for the past three months Patients with ocular surface disorders Patients with a history of previous surgery Patients with a history of allergies
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tear break up time (TBUT). Timepoint: 2, 4 and 6 weeks after starting treatment. Method of measurement: Clinical examination of the patient - per second.;Corneal staining. Timepoint: 2, 4 and 6 weeks after starting treatment. Method of measurement: Clinical examination of the patient with Fluorescein test.;Basic tear secretion rate. Timepoint: 2, 4 and 6 weeks after starting treatment. Method of measurement: Clinical examination of the patient - In millimeters per minute. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMehdi Khaki
Shiraz University of Medical Sciences
Outcome results
None listed